Warnings & Recalls for Enjuvia
Enjuvia and Pregnancy
The
U.S. Food and Drug Administration has assigned Enjuvia as a
pregnancy Category X. Enjuvia is
not approved for use by women who are
pregnant. Enjuvia is not expected to cause harm to the fetus or cause birth defects; however, medically there is
no reason for a woman of childbearing age to use this drug.
Do not Enjuvia if you are pregnant or breastfeeding.
Enjuvia is for
postmenopausal women only.
Risks of Taking Enjuvia
Taking
Enjuvia at
high doses or for an
extended period of time can
increase the risk of:
- breast cancer
- dementia
- gallbladder disease
- heart attack or stroke
- blood clot (especially in legs)
- endometrial cancer
- excessive buildup of cells along the inner lining of the uterus (endometrial hyperplasia)
General Warnings
For safety purposes, patients who have had any of the following should not take Enjuvia: heart attack, stroke or blood clotting disorder, liver disease, unusual bleeding of the vagina or hormone-related cancer including breast or uterine cancer.
Let your doctor know if you have a history of serious health conditions
before using
Enjuvia; this includes:
- any allergies you may have
- any blood pressure, bleeding problems or heart disease
- endometriosis or any other uterine disorders
- kidney disease or failure
- hepatitis (liver disease) or liver tumors
- breathing problems including asthma
- angiodema (swelling beneath the skin)
- epilepsy or any conditions which may cause seizures
- migraine disorders
- diabetes
- hypothyroidism (underactive thyroid)
- nutrient deficiency or high levels of cholesterol or amounts of triglycerides
- any disorders affecting the skin or nervous system (including porphyria)
- systemic lupus erythematosus (lupus)
- disease of the gallbladder
- jaundice or yellowing of the eyes or skin
For women who still have a uterus, progestine may be prescribed to reduce the risk of developing endometrial cancer.
Let your doctor know if you have a history of
smoking or
tobacco use.
Notify your doctor about
any medications you are using or have used recently and be sure to
tell all healthcare providers that you are taking Enjuvia. Inform your doctor of any
surgeries you may have scheduled. You may need to
temporarily discontinue your use of Enjuvia to decrease possible interference with these procedures.
Enjuvia Treatment and Use
Enjuvia | Estrogen is a hormone replacement drug marketed by Teva for treating symptoms of menopause. Side effects which may be treated by Enjuvia include:
- hot flashes
- irritation, dryness or burning of the vagina
- pain of the vagina during intercourse
Enjuvia should not be used for the prevention of heart disease or brain disorders.
Enjuvia is not for women who are of childbearing age. Enjuvia should only be used by postmenopausal women.
How Does Enjuvia Work?
When women begin going through menopause, their body decreases levels of the female sex hormone estrogen, and begins using a different hormone called estrone. This change accounts for the unpleasant symptoms of menopause. Enjuvia reduces and treats these symptoms by producing a combination of 10 different synthetic estrogen hormones to restore balance to the body.
Enjuvia Dosage Information
Enjuvia is given in tablet form to be taken orally. Most women are prescribed to take Enjuvia once each day starting at .3 mg per dose. Dosage and treatment length of using Enjuvia varies depending on the patient’s condition and health. Do not take any amount different than the dose prescribed for your treatment. Read and carefully follow all packaged instructions as well as directions given to you by your doctor.
To prevent future risk , women should take the lowest effective amount of Enjuvia for the shortest time period. View “Warnings and Recalls” tab for information about possible risks which may be increased when taking Enjuvia.
While taking Enjuvia, it is important to have the following examinations to ensure your health:
- breast examination for lumps
- thyroid function test
- blood tests
- physical exam
Let your doctor know if symptoms persist or worsen.